MiRNA expression profilig in 5q-syndrome patiens treated with lenalidomide

Abstrakt

The 5q- syndrome is a subtype of myelodysplastic syndrome (MDS) with characteristic clinical, morphological, cytogenetic[del(5)q31)] and molecular features and well/defined relationship between phenotype and genotype.

Klíčová slova

• 5q- syndrome
• myelodysplastic syndrome (MDS)
• cytogenetic[del(5)q31)] and molecular features
• phenotype
• genotype
• miRNA expression
• lenalidomide